Searchable abstracts of presentations at key conferences in endocrinology

ea0035p325 | Clinical case reports Thyroid/Others | ECE2014

Hypoglycemia in type 1 diabetes mellitus patient – factual ou factitious?

Guelho Daniela , Paiva Isabel , Rodrigues Dircea , Baptista Carla , Saraiva Joana , Moreno Carolina , Dantas Rosa , Vicente Nuno , Cardoso Luis , Carrilho Francisco

Introduction: Factitious hypoglycemia results from surreptitious administration of insulin or insulin secretagogues. It can involve non-diabetic individuals with knowledge of hypoglycemiant drugs, or diabetics manipulating the doses.Clinical case: A 42-year-old women, type 1 diabetic since the age of 14, on intensive insulin therapy (A1C: 8.5%), was hospitalized for study of recurrent severe hypoglycemia in the last 2 months, despite successive insulin d...

ea0035p376 | Diabetes (epidemiology, pathophysiology) | ECE2014

Prevalence of androgenic deficit in men with metabolic alterations

Roman Miriam Menacho , Fernandez Antonio Becerra , Lopez Gilberto Perez , Vicente Rosa Villar , del Rey Sanchez Jose Manuel

Introduction: The syndrome of late-onset hypogonadism (LOH) is a clinical and biochemical syndrome associated with advancing age male, characterized by typical symptoms and decreased serum concentrations of testosterone, which can affect multiple organ systems and may impair quality of life. The prevalence of LOH syndrome is higher in certain patient groups, obese, diabetic and suffering from erectile dysfunction manifest LOH at higher rates than the general population.<p ...

ea0035p1008 | Thyroid (non-cancer) | ECE2014

Recurrence of Graves' disease after radioiodine treatment: factors related to treatment failure

Moreno Carolina , Pires Luis , Cardoso Luis , Ruas Luisa , Saraiva Joana , Guelho Daniela , Vicente Nuno , Costa Gracinda , Carrilho Francisco

Introduction: Radioiodine (RAI) therapy is an inexpensive and reliable therapeutic option for Graves’ disease (GD). However, individual characteristics of the disease can influence therapeutic success. The identification of these factors may help to predict outcome and select optimal pre-treatment conditions.Aim: To assess clinical, laboratory and radioactive parameters that may lead to RAI treatment failure in patients with GD....

ea0035p1009 | Thyroid (non-cancer) | ECE2014

Severe side effects of methimazole in the treatment of hyperthyroidism

Moreno Carolina , Alves Marcia , Paiva Isabel , Rodrigues Dircea , Ruas Luisa , Saraiva Joana , Guelho Daniela , Vicente Nuno , Cardoso Luis , Carrilho Francisco

Introduction: Methimazole is the thionamide compound most used in the treatment of hyperthyroidism due to its efficacy, commodity and security. Severe side effects are rare, although potentially fatal: agranulocytosis in 0.1–0.5% and toxic hepatitis in 0.1%Aims: To characterize the patients admitted in the endocrinology ward for the last 10 years for severe complications of methimazole therapy.Material and Methods: Retrospecti...

ea0032p145 | Calcium and Vitamin D metabolism | ECE2013

Experience in the treatment of primary hyperparathyroidism with cinacalcet: data after 12 months of treatment

Luque-Fernandez Ines , Garcia-Martin Antonia , Luque-Pazos Alessandra , Sastre-Marcos Julia , Vicente-Delgado Almudena , Marco-Martinez Amparo , Canovas Barbara

Introduction: Cinacalcet is an oral calcimimetic indicated in treatment of primary hyperparathyroidism if patients do not accept surgery, do not carry out the surgical criteria, there is failure of previous surgery or serious comorbidity that makes surgery impossible.Methods: Descriptive study that included 20 patients with primary hyperparathyroidism who had complete at least 12 months of treatment with cinacalcet for different reasons (eight patients r...

ea0032p179 | Cardiovascular Endocrinology &amp; Lipid Metabolism | ECE2013

Mediterranean diet modulates the effect of rs1761667 in the CD36 gene on FFA concentration and BMI in a high cardiovascular risk population

Ortega-Azorin Carolina , Godoy Diego , Carrasco Paula , Asensio Eva M , Zanon-Moreno Vicente , Corella Dolores , Sorli Jose V

Introduction and objective: CD36 is a scavenger receptor that facilitates the membrane transport of long chain fatty acids into muscle and adipose tissue. Polymorphisms in this gene have been related to abnormal serum fatty acids and obesity-related phenotypes with inconsistent results. Gene-diet interactions could modulate these associations. Our aim was to study whether a common functional variant (rs1761667) in this gene will associate with anthropometric variables and plas...

ea0032p319 | Clinical case reports - Thyroid / Others | ECE2013

Everolimus. a new therapeutic target in the metastatic neuroendocrine carcinoma

Rodriguez Jose Perez , Hernandez Tomas Martin , Hernandez Cristina , Baz David Vicente , Manzano Virginia Martin , Baldrich Alfonso Gentil , Perez Angel Sendon

Introduction: Everolimus is a drug selective inhibitor of mTOR and approved by the FDA in 2011 for treatment of neuroendocrine tumors of pancreatic origin unresectable. Our objective was to evaluate the efficacy and safety of everolimus in a patient with malignant pancreatic head insulinoma.Case: This is a 31 year old man who complains of epigastric pain, dizziness, sweating and syncope related to exercise. During admission is objectively severe hypoglyc...

ea0032p606 | Female reproduction | ECE2013

Concordance study of pathological results of fertility hormones

Roman Miriam Menacho , Fernandez Antonio Becerra , Lopez Gilberto Perez , Vicente Rosa Villar , del Rey Sanchez Jose Manuel

Introduction: During a normal menstrual cycle, serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2), and progesterone (P4) can vary widely between cycles for the same woman, as well as between different women. Reliable reference values based on the local population are important for correct interpretation of laboratory results.Aims: To evaluate the discrepancy of the results on fertility hormones by two different t...

ea0032p908 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Sleep-apnea and cardiomyopathy in acromegalic patients

Sanchez-Ortiga Ruth , Candela Alfredo , Climent Vicente , Sanchez-Tejada Laura , Monjas-Canovas Irene , Abarca Javier , Moreno-Perez Oscar , Pico Antonio

Introduction: Sleep disordered breathing (SDB) promotes structural myocardial changes and can trigger cardiac arrhythmias. Acromegalic patients have high prevalence of SDB and GH–IGF1 excess is related to a specific cardiomyopathy characterized by concentric cardiac hypertrophy and diastolic dysfunction. The aim of this study was to assess the relationship between SDB and cardiac dysfunction on acromegalic patients.Material and methods: Observationa...

ea0032p941 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Clinical presentation, treatment approach and outcomes of patients with prolactinomas in real-life clinical practice: a single center experience

Vicente Almudena , Satre Julia , Zaballos Florentino , Luque Ines , Luque Alessandra , Castro Enrique , Maqueda Esther , Marco Amparo , Lopez Jose

Introduction: Generously supported by IPSEN)-->Prolactin (PRL) -secreting adenomas are about 40% of all pituitary adenomas. Their clinical symptoms are mainly related to development of secondary hypogonadism and/or tumor mass effects. Dopamine agonists (DA) are first-line drugs for prolactinoma patients due to their effectiveness in normalizing PRL levels and shrinking tumour mass. Surgery is an option for DA failure or tumour mass e...